-Quinagolid%20Structural%20Formula%20V1.svg)
Quinagolide
Also known as (+-)-N,N-Diethyl-N'-((3R*,4aR*,10aS*)-1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo(g)quinolin-3-yl)sulfamide, Quinagolida, Quinagolidum, CV205-502, SDZ 205-502, Norprolac
Quinagolide (, ), sold under the brand name Norprolac, is a selective dopamine D2 receptor agonist which is used to manage hyperprolactinemia. It has also been found to be effective in the treatment of breast pain. It is used in the UK, but it is not available in US.
Key facts
- Drug.image
- Quinagolide.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250px
- Drug.tradename
- Norprolac
- Drug.legal_status
- Rx-only
- Drug.routes_of_administration
- Oral
- Drug.class
- Dopamine receptor agonist
- Drug.ATC_prefix
- G02
- Drug.ATC_suffix
- CB04
- Drug.CAS_number
- 87056-78-8
- Drug.PubChem
- 55645
- Drug.ChemSpiderID
- 2343034
- Drug.DrugBank
Article
5 sectionsContents
- Chemistry
- Synthesis
- Manufacture
- See also
- References
Quinagolide (, ), sold under the brand name Norprolac, is a selective dopamine D2 receptor agonist which is used to manage hyperprolactinemia. It has also been found to be effective in the treatment of breast pain. It is used in the UK, but it is not available in US.
==Chemistry== Quinagolide is a racemate composed of the following two enantiomers:
Gallery (5)
Available in 9 languages
via Wikidata sitelinks · CC0